Archives of Physical Medicine and Rehabilitation
Volume 89, Issue 1 , Pages 56-61 , January 2008

Effect of Botulinum Toxin Injection in the Rectus Femoris on Stiff-Knee Gait in People With Stroke: A Prospective Observational Study

  • Gaëtan G. Stoquart, MD

      Affiliations

    • Rehabilitation and Physical Medicine Unit, Université Catholique de Louvain, Brussels, Belgium
    • Department of Physical Medicine and Rehabilitation, Université Catholique de Louvain, Cliniques Universitaires Saint-Luc, Brussels, Belgium
    • ,
  • Christine Detrembleur, PhD

      Affiliations

    • Rehabilitation and Physical Medicine Unit, Université Catholique de Louvain, Brussels, Belgium
    • ,
  • Sara Palumbo, MD

      Affiliations

    • Department of Physical Medicine and Rehabilitation, Université Catholique de Louvain, Cliniques Universitaires Saint-Luc, Brussels, Belgium
    • ,
  • Thierry Deltombe, MD

      Affiliations

    • Department of Physical Medicine and Rehabilitation, Université Catholique de Louvain, Cliniques Universitaires de Mont-Godinne, Yvoir, Belgium.
    • ,
  • Thierry M. Lejeune, MD, PhD

      Affiliations

    • Rehabilitation and Physical Medicine Unit, Université Catholique de Louvain, Brussels, Belgium
    • Department of Physical Medicine and Rehabilitation, Université Catholique de Louvain, Cliniques Universitaires Saint-Luc, Brussels, Belgium
    • Corresponding Author InformationReprint requests to Thierry M. Lejeune, MD, PhD, Dept of Physical Medicine and Rehabilitation, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Ave Hippocrate 10, B-1200 Brussels, Belgium

References 

  1. Perry J. Gait analysis: normal and pathological function. Thorofare: Slack; 1992;
  2. Riley PO, Kerrigan DC. Torque action of two-joint muscles in the swing period of stiff-legged gait: a forward dynamic model analysis. J Biomech. 1998;31:835–840
  3. Sung DH, Bang HJ. Motor branch block of the rectus femoris: its effectiveness in stiff-legged gait in spastic paresis. Arch Phys Med Rehabil. 2000;81:910–915
  4. Goldberg SR, Anderson FC, Pandy MG, Delp SL. Muscles that influence knee flexion velocity in double support: implications for stiff-knee gait. J Biomech. 2004;37:1189–1196
  5. Goldberg SR, Ounpuu S, Arnold AS, Gage JR, Delp SL. Kinematic and kinetic factors that correlate with improved knee flexion following treatment for stiff-knee gait. J Biomech. 2006;39:689–698
  6. Albert TA, Yelnik A, Bonan I, Lebreton F, Bussel B. Effectiveness of femoral nerve selective block in patients with spasticity: preliminary results. Arch Phys Med Rehabil. 2002;83:692–696
  7. Waters RL, Garland DE, Perry J, Habig T, Slabaugh P. Stiff-legged gait in hemiplegia: surgical correction. J Bone Joint Surg Am. 1979;61:927–933
  8. Chino N, Sonoda S, Domen K, Saitoh E, Kimura A. Stroke impairment assessment set. In:  Chino N,  Melvin JL editor. Functional evaluation of stroke patients. Tokyo: Springer; 1996;p. 19–31
  9. Tsuji T, Liu M, Sonoda S, Domen K, Tsujuchi K, Chino N. The stroke impairment assessment set: its internal consistency and predictive validity. Arch Phys Med Rehabil. 2000;81:863–868
  10. Marks MC, Alexander J, Sutherland DH, Chambers HG. Clinical utility of the Duncan-Ely test for rectus femoris dysfunction during the swing phase of gait. Dev Med Child Neurol. 2003;45:763–768
  11. Dierick F, Penta M, Renaut D, Detrembleur C. A force measuring treadmill in clinical gait analysis. Gait Posture. 2004;20:299–303
  12. Davis RB, Ounpuu S, Tyburski D, Gage JR. A gait analysis data collection and reduction technique. Hum Mov Sci. 1991;10:575–587
  13. Davis BL, Cavanagh PR. Decomposition of superimposed ground reaction forces into left and right force profiles. J Biomech. 1993;26:593–597
  14. Raison M, Detrembleur C, Fisette P, Samin JC, Willems PY. Determination of three-dimensional joint efforts of a subject walking on a treadmill. Comput Methods Biomech Biomed Engin. 2005;(Supp 1):229–230
  15. Van Boxtel GJ, Geraats LH, Van den Berg Lenssen MM, Brunia CH. Detection of EMG onset in ERP research. Psychophysiology. 1993;30:405–412
  16. Mickelborough J, van der Linden ML, Richards J, Ennos AR. Validity and reliability of a kinematic protocol for determining foot contact events. Gait Posture. 2000;11:32–37
  17. McArdle WD, Katch FI, Katch VL. Exercise physiology: energy, nutrition, and human performance. 4th ed.. Philadelphia: Williams & Wilkins; 1996;
  18. Ward AB, Molenaers G, Colosimo C, Berardelli A. Clinical value of botulinum toxin in neurological indications. Eur J Neurol. 2006;13(Suppl 4):20–26
  19. Tate DG, Findley T, Dijkers M, Nobunaga AI, Karunas RB. Randomized clinical trials in medical rehabilitation research. Am J Phys Med Rehabil. 1999;78:486–499
  20. Horn SD, DeJong G, Ryser DK, Veazie PJ, Teraoka J. Another look at observational studies in rehabilitation research: going beyond the holy grail of the randomized controlled trial. Arch Phys Med Rehabil. 2005;86(12 Suppl 2):S8–S15
  21. Benson K, Hartz AJ. A comparison of observational studies and randomized, controlled trials. N Engl J Med. 2000;342:1878–1886
  22. Concato J. Observational versus experimental studies: what’s the evidence for a hierarchy?. NeuroRx. 2004;1:341–347
  23. Sung DH, Jung JY, Kim HD, Ha BJ, Ko YJ. Motor branch of the rectus femoris: anatomic location for selective motor branch block in stiff-legged gait. Arch Phys Med Rehabil. 2003;84:1028–1031
  24. Lejeune TM, Detrembleur C, De Nayer JA, Plaghki LH. Gait analysis and motor point block in dynamic varus of the rear foot in a head injured adult. Arch Phys Med Rehabil. 1996;77:827–829
  25. Buffenoir K, Decq P, Lefaucheur JP. Interest of peripheral anesthetic blocks as a diagnosis and prognosis tool in patients with spastic equinus foot: a clinical and electrophysiological study of the effects of block of nerve branches to the triceps surae muscle. Clin Neurophysiol. 2005;116:1596–1600

 Supported by the Association Nationale d’Aide aux personnes Handicapées (ANAH-Rotary Belgium and Luxemburg), the Fondation du Patrimoine (Université Catholique de Louvain, Brussels), the Fonds National de la Recherche Scientifique, and the Fonds Spécial de Recherche. Botulinum toxin type A (Botox) was provided by Allergan.No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit upon the author(s) or upon any organization with which the author(s) is/are associated.

PII: S0003-9993(07)01614-0

doi: 10.1016/j.apmr.2007.08.131

Archives of Physical Medicine and Rehabilitation
Volume 89, Issue 1 , Pages 56-61 , January 2008

Article Tools

* Image Usage & Resolution